Evaluation of the Treatment of Thoracic & Cardiovascular Disease With Biological Therapy: ClinicalCellRegistry.Com

Status unconfirmed · Phase 2/Phase 3

Conditions studied: Cardiovascular System Diseases (& [Cardiac])

In brief

This is the clinical registry of cell based therapies that is available to researchers around the world. The registry is web based. All researches must provide IRB approval to the coordinating site- University of Utah in order to obtain access to the registry. The are predetermined case report forms for cardiovascular diseases that are currently in clinical trials- including demographics, safety, and possible efficacy end-points. All investigators have access to their own data. The servers are U.S. HIPPA compliant and protected with secure back-up.

Key facts

Study ID

NCT00130377

Run by

Amit N. Patel MD MS

People needed

1000

Starts

2002-08-01

Expected to finish

2020-12-01

Last updated by the study team

2018-01-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age >=18 years old
• Approved consent to be enrolled in trial/registry

You may not qualify if…

• Prior malignancy in the 5 years before treatment in this study (other than curatively treated carcinoma in-situ of the cervix or non-melanoma skin cancer)
• Inability or unwillingness to comply with the treatment protocol, follow-up, research tests, or give consent

Where it is running

• University of Utah — Salt Lake City, Utah, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.